SEC Form 4 · accession 0001683168-17-001479
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wright Don
Director
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 1:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.10 | May 31, 2017 | A | 30,000 | A | — | May 31, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Stock option granted as part of compensation for non-employee directors. Options vest fully on the earlier of (i) May 31, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control. All grants have an exercise price of $1.10 per share.